Figure 3From: Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomicsEstimated annual change of biomarkers in AD patients (n = 45) adjusted for age and sex. Dot, mean change. Line, 95% confidence interval.Back to article page